[EN] NITROGEN-CONTAINING BICYCLIC HETEROCYCLES FOR USE AS ANTIBACTERIALS<br/>[FR] HETEROCYCLES BICYCLIQUES CONTENANT DE L'AZOTE ET UTILISES COMME PRODUITS ANTIBACTERIENS
申请人:SMITHKLINE BEECHAM PLC
公开号:WO2003087098A1
公开(公告)日:2003-10-23
Cyclohexane and cyclohexene derivatives and pharmaceutically acceptable derivatives hereof useful in methods of treatment of bacterial infections in mammals, particularly man.
环己烷和环己烯衍生物及其在哺乳动物,特别是人类细菌感染治疗方法中有用的药用可接受衍生物。
Aminocyclohexene quinolines and their azaisosteric analogues with antibacterial activity
申请人:Davies Thomas David
公开号:US20060040925A1
公开(公告)日:2006-02-23
Cyclohexene derivatives and pharmaceutically acceptable derivatives thereof useful in methods of treatment of bacterial infections in mammals, particularly man.
环己烯衍生物及其药学上可接受的衍生物,适用于哺乳动物,特别是人类的细菌感染治疗方法。
Nitrogen-containing bicyclic heterocycles for use as antibacterials
申请人:——
公开号:US20040171620A1
公开(公告)日:2004-09-02
Cyclohexane and cyclohexene derivatives and pharmaceutically acceptable derivatives hereof useful in methods of treatment of bacterial infections in mammals, particularly man.
Nitrogen-containing bicycle heterocycles for use as antibacterials
申请人:Brooks Gerald
公开号:US20070135422A1
公开(公告)日:2007-06-14
Cyclohexane and cyclohexene derivatives and pharmaceutically acceptable derivatives thereof useful in methods of treatment of bacterial infections in mammals, particularly man.
环己烷和环己烯衍生物及其药学上可接受的衍生物,可用于治疗哺乳动物,特别是人类的细菌感染的方法。
Prodrugs containing novel bio-cleavable linkers
申请人:Piramal Life Sciences Limited
公开号:EP2266623A2
公开(公告)日:2010-12-29
The invention provides the compounds of formula (I) or pharmaceutically acceptable salts thereof. The invention also provides pharmaceutical compositions comprising one or more compounds of formula I or intermediates thereof and one more of pharmaceutically acceptable carriers, vehicles or diluents. The invention further provides methods of preparation and methods of use of prodrugs including NO-releasing prodrugs, double prodrugs and mutual prodrugs comprising the compounds of formula 1.
本发明提供了式 (I) 化合物或其药学上可接受的盐。本发明还提供了包含一种或多种式 I 化合物或其中间体以及一种或多种药学上可接受的载体、载体或稀释剂的药物组合物。本发明进一步提供了包括NO释放原药、双原药和包含式1化合物的互作原药在内的原药的制备方法和使用方法。